| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 57.920 | 68.956 | 28.331 | 24.617 | 24.128 | 21.324 | 15.301 | 12.174 | 10.286 | 9.323 |
| Total Income - EUR | 58.130 | 69.265 | 28.515 | 24.967 | 73.782 | 62.353 | 54.424 | 12.531 | 10.317 | 9.329 |
| Total Expenses - EUR | 58.800 | 66.689 | 29.312 | 25.056 | 26.059 | 48.241 | 29.280 | 13.166 | 11.904 | 10.181 |
| Gross Profit/Loss - EUR | -669 | 2.576 | -797 | -89 | 47.723 | 14.112 | 25.145 | -634 | -1.587 | -852 |
| Net Profit/Loss - EUR | -669 | 1.191 | -1.083 | -337 | 46.829 | 13.440 | 23.315 | -1.003 | -1.587 | -852 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Micropharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 43.347 | 42.125 | 40.324 | 37.458 | 35.291 | 9.797 | 457 | 382 | 308 | 233 |
| Current Assets | 10.476 | 12.424 | 12.216 | 12.966 | 59.913 | 52.301 | 49.814 | 6.089 | 4.831 | 3.997 |
| Inventories | 5.499 | 6.473 | 6.147 | 6.480 | 6.000 | 6.519 | 4.685 | 4.608 | 3.944 | 3.073 |
| Receivables | 2.296 | 2.264 | 2.241 | 2.036 | 27.941 | 22.670 | 34.196 | 138 | 152 | 129 |
| Cash | 2.681 | 3.686 | 3.828 | 4.450 | 25.971 | 23.111 | 10.933 | 1.343 | 736 | 794 |
| Shareholders Funds | 50.474 | 51.150 | 48.031 | 46.813 | 92.735 | 54.463 | 38.218 | 2.983 | 1.387 | 528 |
| Social Capital | 2.317 | 2.294 | 2.255 | 2.213 | 2.171 | 2.129 | 2.082 | 2.089 | 2.082 | 2.071 |
| Debts | 3.364 | 3.606 | 4.622 | 3.648 | 2.592 | 7.731 | 12.054 | 3.488 | 3.752 | 3.702 |
| Income in Advance | 287 | 81 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Micropharma Srl